![Mark Murphy](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Relations actives
Nom | Sexe | Age | Sociétés liées | Collaboration |
---|---|---|---|---|
Robert S. Saunders | M | - |
eBlu Solutions LLC
![]() eBlu Solutions LLC Packaged SoftwareTechnology Services eBlu Solutions LLC is a healthcare technology company based in Louisville, KY. The company provides a secure single-portal software platform for electronic prior authorization and benefits verification in the infusion-based specialty medication space. eBlu Solutions aims to streamline the fragmented nature of the approval process for specialty medication treatments, and currently supports a variety of specialties including rheumatology, neurology, gastroenterology, and allergy & asthma. Despite the COVID pandemic, eBlu Solutions saw its revenue double in 2020 and expects 2021 year over year revenue to more than triple. The company was founded in 2013, and Mark Murphy has been the CEO of the company since 2015. | - |
Tom Hearn | M | - |
eBlu Solutions LLC
![]() eBlu Solutions LLC Packaged SoftwareTechnology Services eBlu Solutions LLC is a healthcare technology company based in Louisville, KY. The company provides a secure single-portal software platform for electronic prior authorization and benefits verification in the infusion-based specialty medication space. eBlu Solutions aims to streamline the fragmented nature of the approval process for specialty medication treatments, and currently supports a variety of specialties including rheumatology, neurology, gastroenterology, and allergy & asthma. Despite the COVID pandemic, eBlu Solutions saw its revenue double in 2020 and expects 2021 year over year revenue to more than triple. The company was founded in 2013, and Mark Murphy has been the CEO of the company since 2015. | - |
Kim Farley | F | - |
eBlu Solutions LLC
![]() eBlu Solutions LLC Packaged SoftwareTechnology Services eBlu Solutions LLC is a healthcare technology company based in Louisville, KY. The company provides a secure single-portal software platform for electronic prior authorization and benefits verification in the infusion-based specialty medication space. eBlu Solutions aims to streamline the fragmented nature of the approval process for specialty medication treatments, and currently supports a variety of specialties including rheumatology, neurology, gastroenterology, and allergy & asthma. Despite the COVID pandemic, eBlu Solutions saw its revenue double in 2020 and expects 2021 year over year revenue to more than triple. The company was founded in 2013, and Mark Murphy has been the CEO of the company since 2015. | - |
Graphique Relationnel
Relation dans plusieurs entreprises
Statistiques
Pays | Relations | % du total |
---|---|---|
Etats-Unis | 3 | 100,00% |
Age des relations
Actives
Passées
Homme
Femme
Administrateurs
Exécutifs
Provenance des relations
- Bourse
- Insiders
- Mark Murphy
- Réseau Personnel